983 related articles for article (PubMed ID: 25803181)
1. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
2. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
3. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal membrane oxygenation in the treatment of poisoned patients.
de Lange DW; Sikma MA; Meulenbelt J
Clin Toxicol (Phila); 2013 Jun; 51(5):385-93. PubMed ID: 23697460
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal membrane oxygenation for intraoperative cardiac support in children with congenital heart disease.
Delmo Walter EM; Alexi-Meskishvili V; Huebler M; Loforte A; Stiller B; Weng Y; Berger F; Hetzer R
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):753-8. PubMed ID: 20139198
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
[TBL] [Abstract][Full Text] [Related]
7. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with respiratory and heart failure: review of our experience.
Goto T; Suzuki Y; Suzuki Y; Osanai A; Aoki K; Yamazaki A; Daitoku K; Fukuda I
Artif Organs; 2011 Nov; 35(11):1002-9. PubMed ID: 22097977
[TBL] [Abstract][Full Text] [Related]
8. Total Artificial Heart Implantation as a Bridge to Heart Transplantation in an Active Duty Service Member With Amyloid Cardiomyopathy.
Scully MS; Wessman DE; McKee JM; Francisco GM; Nayak KR; Kobashigawa JA
Mil Med; 2017 Mar; 182(3):e1858-e1860. PubMed ID: 28290973
[TBL] [Abstract][Full Text] [Related]
9. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous bi-atrial extracorporeal membrane oxygenation for acute circulatory support in advanced heart failure.
Jumean M; Pham DT; Kapur NK
Catheter Cardiovasc Interv; 2015 May; 85(6):1097-9. PubMed ID: 25529821
[TBL] [Abstract][Full Text] [Related]
11. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.
Ng B; Connors LH; Davidoff R; Skinner M; Falk RH
Arch Intern Med; 2005 Jun; 165(12):1425-9. PubMed ID: 15983293
[TBL] [Abstract][Full Text] [Related]
12. Baseline MELD-XI score and outcome from veno-arterial extracorporeal membrane oxygenation support for acute decompensated heart failure.
Sern Lim H
Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):82-88. PubMed ID: 26452667
[TBL] [Abstract][Full Text] [Related]
13. Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis.
Schattner A; Epstein M; Berrebi A; Caspi A
Am J Med Sci; 1995 Dec; 310(6):256-7. PubMed ID: 7503107
[TBL] [Abstract][Full Text] [Related]
14. Cardiac amyloidosis in a patient with multiple myeloma: a case report and review of literature.
Sedaghat D; Zakir RM; Choe J; Klapholz M; Saric M
J Clin Ultrasound; 2009; 37(3):179-84. PubMed ID: 19177424
[TBL] [Abstract][Full Text] [Related]
15. Primary (AL) amyloidosis in plasma cell disorders.
Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin light chain amyloidosis and the kidney.
Gertz MA; Lacy MQ; Dispenzieri A
Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079
[TBL] [Abstract][Full Text] [Related]
17. The use of percutaneous ECMO support as a 'bridge to bridge' in heart failure patients: a case report.
Fitzgerald D; Ging A; Burton N; Desai S; Elliott T; Edwards L
Perfusion; 2010 Sep; 25(5):321-5, 327. PubMed ID: 20634225
[TBL] [Abstract][Full Text] [Related]
18. The role of extracorporeal membrane oxygenation (ECMO) therapy in acute heart failure.
Tsuneyoshi H; Rao V
Int Anesthesiol Clin; 2012; 50(3):114-22. PubMed ID: 22735722
[TBL] [Abstract][Full Text] [Related]
19. Veno-arterial ECMO in severe acute right ventricular failure with pulmonary obstructive hemodynamic pattern.
Belohlavek J; Rohn V; Jansa P; Tosovsky J; Kunstyr J; Semrad M; Horak J; Lips M; Mlejnsky F; Balik M; Klein A; Linhart A; Lindner J
J Invasive Cardiol; 2010 Aug; 22(8):365-9. PubMed ID: 20679672
[TBL] [Abstract][Full Text] [Related]
20. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support.
Thourani VH; Kirshbom PM; Kanter KR; Simsic J; Kogon BE; Wagoner S; Dykes F; Fortenberry J; Forbess JM
Ann Thorac Surg; 2006 Jul; 82(1):138-44; discussion 144-5. PubMed ID: 16798204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
